Pembrolizumab’s Targeting of MSI-H-dMMR Colorectal Cancers More Effective Than Chemotherapy
The New England Journal of Medicine recently carried a report citing data from a Phase 3 clinical trial involving 307 people diagnosed with MSI-H-dMMR metastatic colorectal cancer. MSI-H (high levels…